Starling Oncology, Inc. (STLN): Form 8-K filed 2026-09-02
- Accepted by EDGAR
- 2026-09-01 20:41 ET
- Event date
- 2026-09-01
- Accession no.
- 0001079973-26-001208
- Original filing
- SEC EDGAR filing index
Items reported
- Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | stln_8k.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.